ReviewMolecular neurobiology2025
Emerging Trends and Hot Spots in Epigenetic Modifications in Neurology: A Bibliometric Analysis.
Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The complement cascade in Alzheimer's disease: modern implications of an ancient immune protagonist.Molecular neurodegeneration · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study employs a bibliometric analysis to examine the evolution and future trajectories in epigenetic modifications in neurology from 2004 to 2024. A total of 12,964 publications were scrutinized via the R bibliometrix package and VOSviewer for network visualization, complemented by Scimagp Graphica to elucidate global collaborative networks. Our extensive review reveals a significant growth in the field of epigenetic neurology studies, driven by an increased output of publications and evidenced by an enhanced focus on epigenetic modifications. The USA and McGill University are recognized as central contributors, with Nature leading as the most prolific journal and J. Mill and E.J. Nestler distinguishing themselves as key authors by publication volume and citation impact, respectively. A detailed keyword analysis highlighted "expression," "DNA methylation," "brain," "gene-expression," and "gene" as the most recurrent terms, indicating core areas of research concentration. Subsequent manual analysis due to software-detected inaccuracies reaffirmed Alzheimer's disease, cancer, and schizophrenia as predominant neurological diseases associated with epigenetic studies. Pathophysiological processes such as DNA methylation, oxidative stress, and synaptic plasticity have been extensively examined in relation to epigenetic modifications in neurology. Synthesis of the reference literature analysis identifies critical themes such as the role of glucocorticoid receptors, the significance of hydroxymethylcytosine in neural DNA, the implications of epigenetic patterns in mental health, and the impact of BDNF gene on memory consolidation. Emerging technologies and underexplored areas further highlight future directions. These insights into epigenetic research in neurology indicate a sustained and intensifying trajectory, hinting at expanding horizons for future therapeutic approaches and interventions. Our findings underscore an active and progressing interest in neurological epigenetics, suggesting a continued expansion and specialization in the exploration of epigenetic mechanisms and their clinical relevance.
Indexed as
Identifiers
40216692What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.